ARPA-H Rare Disease AI/ML and Precision Integrated Diagnostics (RAPID) Patients’ Day
ID: ARPA-H-SN-25-127Type: Special Notice
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNIH ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)Bethesda, MD, 208920004, USA

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

PSC

HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT (AN13)

Original Source

https://sam.gov/opp/229d3cd40bbe46d9892c4e2ea4090d79/view
Timeline
  1. 1
    Posted Jan 13, 2025, 12:00 AM UTC
  2. 2
    Updated Feb 21, 2025, 12:00 AM UTC
  3. 3
    Due Feb 21, 2025, 5:00 PM UTC
Description

The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is hosting a virtual Patients’ Day on February 25, 2025, to introduce the RAPID Program, which focuses on utilizing artificial intelligence (AI) and machine learning (ML) for precision diagnostics in rare diseases. The event aims to provide insights into the ARPA-H mission, program goals, and the involvement of Patient Experience (PX) Partners, encouraging participation from patient advocacy groups to enhance the development of innovative diagnostic support tools and comprehensive data integration. This initiative is crucial for addressing the diagnostic challenges faced by rare disease patients, particularly in democratizing access to diagnostics for underserved communities. Registration for the event opens on December 19, 2024, and closes on February 21, 2025; interested parties can reach out to the RAPID Email Box at RAPID@ARPA-H.gov for further information.

Point(s) of Contact
RAPID Email Box
RAPID@ARPA-H.gov
Files
Title
Posted
RAPID_PXP_Day_Special Notice_FINAL.pdf
Feb 21, 2025, 5:05 PM UTC
The Advanced Research Projects Agency for Health (ARPA-H) has announced a virtual Patients’ Day on February 25, 2025, aimed at introducing the RAPID Program, which focuses on employing AI and ML for precision diagnostic solutions in rare diseases. The event will provide insights about the ARPA-H mission, program goals, and the role of Patient Experience (PX) Partners, urging participation from patient advocacy groups. Registration for the event opens on December 19, 2024, and closes on February 21, 2025. The RAPID Program intends to end the diagnostic odyssey faced by rare disease patients by developing innovative diagnostic support tools and fostering comprehensive data integration. It will operate through several technical areas, including creating a massive rare disease dataset, leveraging novel diagnostic indicators, and developing a sustainable platform for AI diagnostic development. RAPID aims to democratize diagnostic access, ensuring benefits for underserved communities while promoting trust and engagement with patients throughout the research and diagnostic development process. This notice emphasizes participation in Patients’ Day as optional, with comprehensive details on PX Partner roles and program structure shared during the event.
Lifecycle
Title
Type
ARPA-H Rare Disease AI/ML and Precision Integrated Diagnostics (RAPID) Patients’ Day
Currently viewing
Special Notice
Similar Opportunities
Office-Wide Innovative Solutions Opening for Health Science Futures (HSF)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Innovative Solutions Opening (ISO) aimed at advancing healthcare technologies. This initiative seeks innovative, disease-agnostic research projects that can significantly improve health outcomes, focusing on areas such as maternal and fetal health, genetic therapies, and novel diagnostic tools. The solicitation emphasizes the development of transformative solutions rather than incremental research, with submissions required to follow a two-step process: an initial solution summary followed by a full proposal based on feedback received. Interested parties must submit their solution summaries by March 3, 2029, via the designated ARPA-H portal, and are encouraged to review the detailed submission guidelines outlined in the provided documentation.
Office-Wide Innovative Solutions Opening for Scalable Solutions Office (SSO)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative solutions aimed at enhancing healthcare accessibility, affordability, and scalability. This opportunity invites universities, non-profits, small businesses, and similar entities to submit solution summaries and proposals that address health disparities, improve the distribution of healthcare technologies, and advance biomanufacturing innovations. The solicitation emphasizes the development of scalable technologies and collaborative distribution networks, with a focus on interdisciplinary approaches to revolutionize biomedicine and public health outcomes. Interested parties must submit their solution summaries by March 3, 2029, and can find further details and submission guidelines at https://solutions.arpa-h.gov. For inquiries, questions should be directed to the same website.
Office-Wide Innovative Solutions Opening for Resilient Systems Office (RSO)
Buyer not available
The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative solutions aimed at enhancing the resilience of healthcare systems via its Resilient Systems Office (RSO). This opportunity invites submissions from eligible entities, including universities, nonprofits, and small businesses, to address systemic challenges in healthcare and public health by leveraging cutting-edge technologies that improve care quality and availability. The solicitation emphasizes the importance of sociotechnical system innovations and adaptive solutions that enhance the reliability and interoperability of health ecosystems. Interested parties must submit solution summaries for feedback before full proposal submissions, with the solicitation open until March 3, 2029. For further inquiries, submissions should be directed to the designated online platforms, and the primary contact email is provided in the solicitation details.
PROactive Solutions for Prolonging Resilience (PROSPR)
Buyer not available
The Department of Health and Human Services, through the Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the PROactive Solutions for Prolonging Resilience (PROSPR) program, aimed at extending the healthspan of Americans by 20 years. This initiative invites eligible applicants to develop innovative interventions focused on early disease prevention and addressing age-related health decline, which significantly impacts healthcare costs. The program encompasses three Technical Areas: developing a precise intrinsic capacity score for health predictions, repurposing FDA-approved drugs to enhance healthspan, and testing second-generation healthspan interventions through clinical trials. Interested parties can find more information and submit inquiries to the PROSPR Team at PROSPR@arpa-h.gov, with proposals due by the specified deadlines outlined in the solicitation documents.
Research and Development of the FDA ARGOS System
Buyer not available
The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking qualified vendors for the research and development of the FDA ARGOS System, as outlined in a Sources Sought Notice. The primary objective is to enhance the FDA ARGOS database and develop bioinformatics and artificial intelligence tools to analyze genetic data, thereby improving public health preparedness and regulatory processes related to medical countermeasures against infectious diseases. This initiative is crucial for advancing diagnostic capabilities through Next Generation Sequencing (NGS) technology, which can identify microbial pathogens efficiently and accurately. Interested parties must submit their responses, including a Vendor Feedback Form, to Nicholas Bisher and Kimberly Pennix by May 2, 2025, at 2:00 PM EST, as no solicitation is currently available.
Pharmacogenomics (PGx) Testing for Military Readiness Pilot
Buyer not available
The Department of Defense, through the Defense Health Agency (DHA), is seeking proposals for a pilot program focused on pharmacogenomics (PGx) testing to enhance military readiness and healthcare delivery for Active-Duty service members. The initiative aims to establish standardized processes for routine PGx testing within the Military Health System (MHS), leveraging electronic health record (EHR) data to improve clinical decision-making and treatment outcomes. This program is critical for optimizing medication safety and efficacy, ultimately preventing adverse drug reactions and improving overall health conditions for military personnel. Interested parties should contact Dr. Lauren Palestrini at lauren.palestrini@mtec-sc.org, with a funding availability of $2.2 million and a project duration of up to 36 months. The Request for Project Proposals (RPP) is expected to be released soon, with a proposal preparation period of approximately 30 days.
RRPV Solicitation Summary: Central Influenza and Emerging Infectious Diseases Vaccine Immunogenicity Laboratory Services
Buyer not available
The Department of Health and Human Services, through the Biomedical Advanced Research and Development Authority (BARDA), is seeking proposals for the establishment of a Central Influenza and Emerging Infectious Diseases Vaccine Immunoassay Laboratory. This initiative aims to enhance national health security by facilitating the rapid development of vaccines in response to potential pandemics, with a focus on conducting immunoassays to support vaccine research and clinical trials. The successful offeror will play a critical role in strengthening biodefense infrastructure by providing standardized laboratory services, with proposals due by May 30, 2025, and questions accepted until April 24, 2025. Interested parties can contact Rebecca Harmon at rebecca.harmon@ati.org for further information.
Remote Health Readiness Program 4 (RHRP-4)
Buyer not available
The Department of Defense, through the Defense Health Agency (DHA), is soliciting proposals for the Remote Health Readiness Program 4 (RHRP-4), aimed at providing comprehensive medical and dental readiness services to military personnel, including active and reserve components, as well as Department of Homeland Security members. The contract, structured as an Indefinite Delivery Indefinite Quantity (IDIQ) agreement, will span ten years and is valued at a maximum of $1.61 billion, focusing on maintaining the health and readiness of service members through various assessments, treatments, and logistical support. This initiative underscores the importance of ensuring a medically ready force, with contractors required to establish a network of certified providers and adhere to strict quality control and reporting standards. Interested parties must submit their proposals by May 9, 2025, and can direct inquiries to Nakaura C. Yusuf at nakaura.c.yusuf.civ@health.mil or by phone at 703-681-5821.
FDA NCTR On-Site Pathology Services
Buyer not available
The U.S. Food and Drug Administration (FDA) is preparing to solicit comprehensive on-site animal pathology services for its National Center for Toxicological Research (NCTR) to support its research programs aimed at public health protection. The required services will encompass a variety of pathology support tasks, including necropsies, histopathology, and specialized techniques such as immunohistochemistry and respiratory pathology, as dictated by research protocols from Principal Investigators. This opportunity is significant for businesses in the professional, scientific, and technical services sector, with the solicitation number 75F40125R00059 expected to be released around April 30, 2025, and a closing date set for 30 days post-release. Interested parties should monitor SAM.gov for updates and can contact Tim Walbert at timothy.walbert@fda.hhs.gov or 870-543-7267 for further information.
Research, Measurement, Assessment, Design, and Analysis (RMADA) 3 IDIQ
Buyer not available
The Department of Health and Human Services, specifically the Centers for Medicare and Medicaid Services (CMS), is seeking proposals for the Research, Measurement, Assessment, Design, and Analysis (RMADA) 3 Indefinite Delivery Indefinite Quantity (IDIQ) contract. This contract aims to provide analytic support and technical assistance for healthcare models and demonstration programs under the Affordable Care Act, focusing on reducing expenditures for Medicare, Medicaid, and CHIP beneficiaries while maintaining or improving the quality of care. The contract has a maximum ceiling of $3.5 billion over its duration, with a minimum order threshold of $1,500, and will involve tasks such as data analysis, stakeholder engagement, and program evaluations. Interested parties must submit their proposals by the revised deadline of May 6, 2025, and can direct inquiries to Melanie Suris-Rodriguez at RMADA3@cms.hhs.gov.